Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Alopecia areata negatively affects self-esteem, relationships, and academics in young people.

Steroids are the best treatment for Alopecia Areata with few side effects.

Upadacitinib may effectively treat alopecia areata without side effects.

The formulated gel is a promising treatment for alopecia areata.

Effective alopecia treatments exist, but high costs and limited access remain challenges.

Nail changes are common in alopecia areata and can indicate its severity.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Upadacitinib improved multiple immune-related conditions in one patient.

Tailored combination therapy improves non-scarring alopecia outcomes.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Balding in men worsens with age.

The study suggests that hypothyroidism may cause alopecia areata.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

These gene variations are not linked to alopecia areata in Egyptians.

Melanocyte stem cells from non-affected skin in vitiligo patients can become functional melanocytes for potential therapy.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.